These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31321907)

  • 41. Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromes.
    Hamidi A; Roloff GW; Shaw R; Acevedo M; Smith S; Drazer MW
    Leuk Lymphoma; 2023 Sep; 64(9):1562-1565. PubMed ID: 37294121
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toward Standardization of Flow-Cytometric Immunophenotyping for the Diagnosis and Monitoring of Hematologic Malignancies.
    Kim SY; Huh HJ
    Ann Lab Med; 2024 May; 44(3):193-194. PubMed ID: 38145894
    [No Abstract]   [Full Text] [Related]  

  • 43. Myeloproliferative neoplasms: Diagnostic workup of the cythemic patient.
    Wong WJ; Pozdnyakova O
    Int J Lab Hematol; 2019 May; 41 Suppl 1():142-150. PubMed ID: 31069979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Considerations and recommendations for a new molecular diagnostic algorithm for the myeloproliferative neoplasms.
    Haslam K; Langabeer SE
    Genet Test Mol Biomarkers; 2014 Nov; 18(11):749-53. PubMed ID: 25259626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LNK mutations in familial myeloproliferative neoplasms.
    Rumi E; Harutyunyan AS; Pietra D; Feenstra JD; Cavalloni C; Roncoroni E; Casetti I; Bellini M; Milanesi C; Renna MC; Gotti M; Astori C; Kralovics R; Cazzola M
    Blood; 2016 Jul; 128(1):144-5. PubMed ID: 27216218
    [No Abstract]   [Full Text] [Related]  

  • 47. Genomic analysis of clonal eosinophils by CGH arrays reveals new genetic regions involved in chronic eosinophilia.
    Arefi M; Robledo C; Peñarrubia MJ; García de Coca A; Cordero M; Hernández-Rivas JM; García JL
    Eur J Haematol; 2014 Nov; 93(5):422-8. PubMed ID: 24813417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiparameter immunophenotypic analysis of fine needle aspiration biopsies and other hematologic specimens by laser scanning cytometry.
    Clatch RJ; Walloch JL
    Acta Cytol; 1997; 41(1):109-22. PubMed ID: 9022735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in the World Health Organization 2016 classification of myeloid neoplasms everyone should know.
    Hasserjian RP
    Curr Opin Hematol; 2018 Mar; 25(2):120-128. PubMed ID: 29256927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The immunology laboratory in malignant blood diseases].
    López Berges MC; Vidriales B; Ocqueteau M; Orfao A
    Sangre (Barc); 1996 Aug; 41(4):281-8. PubMed ID: 8984669
    [No Abstract]   [Full Text] [Related]  

  • 51. Molecular characterization of chronic myeloproliferative neoplasias in México.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Ortiz-López R; Rivas-Llamas R; Gómez-Almaguer D; Ruiz-Delgado GJ
    Hematology; 2009 Oct; 14(5):261-5. PubMed ID: 19843380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomic analysis of myeloproliferative neoplasms in chronic and acute phases.
    Courtier F; Carbuccia N; Garnier S; Guille A; Adélaïde J; Cervera N; Gelsi-Boyer V; Mozziconacci MJ; Rey J; Vey N; Chaffanet M; Birnbaum D; Murati A
    Haematologica; 2017 Jan; 102(1):e11-e14. PubMed ID: 27742771
    [No Abstract]   [Full Text] [Related]  

  • 53. 8p11 myeloproliferative syndrome: a case report of this rare clinical entity.
    Rahman K; Kamboj M; Qayoom S; Khurana A
    Indian J Pathol Microbiol; 2015; 58(2):254-5. PubMed ID: 25885151
    [No Abstract]   [Full Text] [Related]  

  • 54. Flow cytometry immunophenotyping of hematolymphoid neoplasia.
    Calvo KR; McCoy CS; Stetler-Stevenson M
    Methods Mol Biol; 2011; 699():295-316. PubMed ID: 21116989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome.
    Bain BJ; Fletcher SH
    Immunol Allergy Clin North Am; 2007 Aug; 27(3):377-88. PubMed ID: 17868855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EuroFlow and its activities: Introduction to the special EuroFlow issue of The Journal of Immunological Methods.
    van Dongen JJM; O'Gorman MRG; Orfao A
    J Immunol Methods; 2019 Dec; 475():112704. PubMed ID: 31758969
    [No Abstract]   [Full Text] [Related]  

  • 57. An online decision support system for diagnosing hematopoietic malignancies by flow cytometry immunophenotyping.
    Qian YW; Mital D; Lee S
    AMIA Annu Symp Proc; 2007 Oct; ():1084. PubMed ID: 18694182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Flow cytometry vs cytomorphology for the detection of hematologic malignancy in body cavity fluids.
    Cesana C; Klersy C; Scarpati B; Brando B; Volpato E; Bertani G; Faleri M; Nosari A; Cantoni S; Ferri U; Scampini L; Barba C; Lando G; Morra E; Cairoli R
    Leuk Res; 2010 Aug; 34(8):1027-34. PubMed ID: 20206995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Notch one up to stroma: endothelial notch prevents inflammation and myeloproliferation.
    Khalaj M; Park CY
    Cell Stem Cell; 2014 Jul; 15(1):1-2. PubMed ID: 24996160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. JAK2 (and other genes) be nimble with MPN diagnosis, prognosis, and therapy.
    Ciboddo M; Mullally A
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):110-117. PubMed ID: 30504299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.